Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

GlobeNewswire

01-30

New RED Certara LOGO-CMYK-01.png

RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26^th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.

Certara also announced that company management will participate in the following investor conferences:

Leerink Partners Global Healthcare Conference
Date and Time: Tuesday, March 11^th at 1:00PM ET

Barclays 27^th Annual Global Healthcare Conference
Date and Time: Wednesday, March 12^th at 11:30AM ET

Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Alyssa Horowitz
certara@pancomm.com

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2507665991"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507665991\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2507665991?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-30 05:15","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2507665991","market":"us","top_or_hot":-1,"title":"Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences","media":"GlobeNewswire","content":"<html><body><img hspace=\"5\" src=\"https://s.yimg.com/uu/api/res/1.2/tPL.Lx38X9J9JIzZrh1M4w--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/globenewswire.com/a00b95c10d6c374dcacb336e0f417911\" title=\"New RED Certara LOGO-CMYK-01.png\" vspace=\"5\"/>\n<p>RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/CERT\">Certara, Inc.</a> (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26<sup>th</sup>, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.</p>\n<p>Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.</p>\n<p>Certara also announced that company management will participate in the following investor conferences:</p>\n<ul type=\"disc\">\n<li><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date and Time:</strong> Tuesday, March 11<sup>th</sup> at 1:00PM ET<br/></li>\n</ul>\n<ul type=\"disc\">\n<li><strong>Barclays 27</strong><sup><strong>th</strong></sup><strong> Annual Global Healthcare Conference</strong><br/><strong>Date and Time:</strong> Wednesday, March 12<sup>th</sup> at 11:30AM ET<br/></li>\n</ul>\n<p>Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.</p>\n<p><strong>About Certara</strong><br/>Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.<br/></p>\n<p><strong>Investor Relations Contact:</strong><br/>David Deuchler<br/>Gilmartin Group<br/>ir@certara.com<br/><br/><br/></p>\n<p><strong>Media Contact:</strong><br/>Alyssa Horowitz<br/>certara@pancomm.com<br/><br/></p>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCertara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">GlobeNewswire</strong><span class=\"h-time small\">2025-01-30 05:15</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><img hspace=\"5\" src=\"https://s.yimg.com/uu/api/res/1.2/tPL.Lx38X9J9JIzZrh1M4w--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/globenewswire.com/a00b95c10d6c374dcacb336e0f417911\" title=\"New RED Certara LOGO-CMYK-01.png\" vspace=\"5\"/>\n<p>RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/CERT\">Certara, Inc.</a> (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26<sup>th</sup>, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.</p>\n<p>Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.</p>\n<p>Certara also announced that company management will participate in the following investor conferences:</p>\n<ul type=\"disc\">\n<li><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date and Time:</strong> Tuesday, March 11<sup>th</sup> at 1:00PM ET<br/></li>\n</ul>\n<ul type=\"disc\">\n<li><strong>Barclays 27</strong><sup><strong>th</strong></sup><strong> Annual Global Healthcare Conference</strong><br/><strong>Date and Time:</strong> Wednesday, March 12<sup>th</sup> at 11:30AM ET<br/></li>\n</ul>\n<p>Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.</p>\n<p><strong>About Certara</strong><br/>Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.<br/></p>\n<p><strong>Investor Relations Contact:</strong><br/>David Deuchler<br/>Gilmartin Group<br/>ir@certara.com<br/><br/><br/></p>\n<p><strong>Media Contact:</strong><br/>Alyssa Horowitz<br/>certara@pancomm.com<br/><br/></p>\n<br/></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/certara-report-fourth-quarter-full-211500166.html\">GlobeNewswire</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"醫療保健技術","start_time":0,"source_url":"https://finance.yahoo.com/news/certara-report-fourth-quarter-full-211500166.html","article_id":"2507665991","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507665991","pubTimestamp":1738185300,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"RADNOR, Pa., Jan. 29, 2025  -- Certara, Inc. , a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.Certara also announced that company management will participate in the following investor conferences:. Leerink Partners Global Healthcare ConferenceDate and Time: Tuesday, March 11th at 1:00PM ET. Barclays 27th Annual Global Healthcare ConferenceDate and Time: Wednesday, March 12th at 11:30AM ET. About CertaraCertara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutica","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","CERT":"Certara, Inc."},"translate_title":"Certara将于2025年2月26日报告2024年第四季度和全年财务业绩，并参加即将举行的投资者会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERT":1},"content_text":"RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.\nInvestors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.\nCertara also announced that company management will participate in the following investor conferences:\n\nLeerink Partners Global Healthcare ConferenceDate and Time: Tuesday, March 11th at 1:00PM ET\n\n\nBarclays 27th Annual Global Healthcare ConferenceDate and Time: Wednesday, March 12th at 11:30AM ET\n\nLive and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.\nAbout CertaraCertara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.\nInvestor Relations Contact:David DeuchlerGilmartin Groupir@certara.com\nMedia Contact:Alyssa Horowitzcertara@pancomm.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}